1197. E. faecium: A Tale of Two Organisms
Session: Symposium: Vancomycin-Resistant Enterococcus
Saturday, October 5, 2013: 8:30 AM
Room: The Moscone Center: 104 (Gateway Ballroom)
Barbara Murray, MD, FIDSA, University of Texas Medical School, Houston, TX


Current: Director, Division of Infectious Diseases, and Vice-chair for Research, Department of Internal Medicine; Professor, Department of Internal Medicine and Department of Microbiology and Molecular Genetics, University of Texas Medical School at Houston; Co-director, Center for the Study of Emerging and Re-Emerging Pathogens. M.D.: University of Texas Southwestern Medical School in Dallas, 1973; Residency and Infectious Diseases Fellowship, Massachusetts General Hospital, Boston, 1973-79.
Member: American Society for Microbiology 1978-present; ICAAC Planning Committee, 1984-1988 and 1996-2003, Vice Chair, 1998-2000, Chair, 2001-2003; Hoechst-Roussel Award Committee, 1985-1988; Chair, Hoechst Marion Roussel Award Committee, 1998-2000; Welcome Visiting Professorship Committee, 1989-92; Editorial Board, Antimicrobial Agents and Chemotherapy, 1985-present and Editor, 1992-2002; Chair, Division A, 1996. Member: Infectious Diseases Society of America, 1980-present; Journal of Infectious Diseases Editorial Board, 1986-89 and 2004-present; IDSA Squibb Award and Bristol Award Committees, 1989-93; IDSA Publications Committee, 1990-93; IDSA Finance Committee, 1996-1998; Maxwell Finland Lecturer, 1996; Secretary-Treasurer (elected), 2003-present. Member: International Society for Infectious Diseases, 1990-present, Council, 1991-1996; Executive Committee, 1996-1999. Member: American Society for Clinical Investigation, 1985-present; Council, 1988-89; Vice President, 1989-90; Editorial Committee, Journal of Clinical Investigation, 1990-1995. Member: Association of American Physicians, 1997-present. NIH Recombinant DNA Advisory Committee,1989-92, Chair, 1991-92. NIH Study Section for Bacteriology and Mycology, 1993-97. Chair, NIH Data and Safety Monitoring Board for the Clinical Studies of Chronic Lyme Disease, 1997-2000. NIH-NIAID Therapeutics Data and Safety Monitoring Board, 2003-present; FDA Anti-Infectives Advisory Committee, 1998-2002. Board of Directors and Medical Director for Amigos de las Americas, a non-profit volunteer organization, 1984-90. Board of Directors, National Foundation for Infectious Diseases, 1996-1999. Dr. Murray has been a frequent invited speaker at IDSA, ISID, ICC, ASM, ECCMID and other international meetings, symposia, Grand Rounds, and at ASM and ICAAC workshops; she is active on a number of advisory and/or data safety and monitoring boards. In addition to over 180 peer-reviewed publications, Dr. Murray has authored a number of chapters and invited review articles and commentaries on enterococci, antibiotics and antibiotic resistance, and molecular epidemiologic techniques for analyzing microorganisms. Research efforts (currently funded by two NIH grants, including a MERIT award, and pharmaceutical companies) have focused on mechanisms of antibiotic resistance; the molecular epidemiology of antibiotic resistance organisms; and enterococci - their antimicrobial resistance and their mechanisms of virulence.

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.